Why do cancer cells become "addicted" to oncogenic epidermal growth factor receptor?
Mellinghoff
Ingo
I
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA. mellingi@mskcc.org
D000818:Animals; D045744:Cell Line, Tumor; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors